MacroGenics, Inc. (MGNX) is a publicly traded Healthcare sector company. As of October 26, 2026, MGNX trades at $2.29 with a market cap of $143.33M and a P/E ratio of -16.11. MGNX moved +1.78% today. Year to date, MGNX is +39.75%; over the trailing twelve months it is +22.95%. Its 52-week range spans $0.99 to $5.08. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces MGNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover MGNX: 0 strong buy, 2 buy, 2 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $7.00.
| Metric | Value |
|---|---|
| Price | $2.29 |
| Market Cap | $143.33M |
| P/E Ratio | -16.11 |
| EPS | $-0.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.08 |
| 52-Week Low | $0.99 |
| Volume | 75.75K |
| Avg Volume | 0 |
| Revenue (TTM) | $153.62M |
| Net Income | $-14.59M |
| Gross Margin | 0.00% |
4 analysts cover MGNX: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.